Healthcare and Life Science
New partnership with UNESCO supports the Human Cell Atlas Project
A new partnership between the Human Cell Atlas (HCA) and the United Nations Educational, Scientific and Cultural Organization (UNESCO) will help advance open science and global capacity to deliver the benefits of genomics at a global scale. ...
Trust consultant honoured with Arnold Adolf Berthold award
An Addenbrooke’s honorary consultant who has won top accolades for his cutting-edge work has just been presented with another. ...
Arecor enters collaboration with major global pharmaceutical partner
Cambridge: Arecor Therapeutics plc, the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that it has signed a formulation study agreement with a major global pharmaceutical partner. ...
China’s Neurotechnology breakthrough: A new era for Paralysis treatment
In the vibrant metropolis of Shanghai, a quiet revolution is unfolding that could reshape the future of medicine and technology. ...
Scientists unlock secret behind how smoking and drinking alcohol causes cancer
Scientists have revealed exactly how tobacco smoke damages DNA to drive the development of different types of head and neck cancer, a finding that could unlock new treatments and prevention strategies. ...
CMR Surgical secures more than $200M to accelerate growth
CMR Surgical, the global surgical robotics company, announces the successful closing of a financing round of over $200 million through a combination of equity and debt capital to support the company’s ambitious growth plans. ...
World-first trial indicates immunosuppression may help treat Parkinson’s
A groundbreaking trial, led from Cambridge, has revealed that immunosuppressing medicines show promise for the treatment of Parkinson’s disease, according to results presented this weekend at the world’s most prestigious neurodegeneration conference AD/PD. ...
AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing
AstraZeneca announces an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance life sciences in China. ...
Rapid growth of blood cancer driven by a single genetic 'hit'
A new study has unveiled when chronic myeloid leukaemia, a type of cancer that affects the blood and bone marrow, arises in life and how fast it grows. Researchers reveal explosive growth rates of cancerous cells years before diagnosis and variation in these rates of growth between pati...
Killer50 companies raise megabucks in Q1 2025
Business Weekly newsdesk writes: Seven companies in The Killer50 pantheon compiled by Business Weekly have collectively raised almost $1/2 billion in the first quarter of 2025 alone. Two were in our Technology top 50 and five in the Life Sciences cohort. ...